# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-049248
Filing Date
2024-04-26
Accepted
2024-04-26 16:45:10
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | clsd_ars_2023.pdf | ARS | 732762
| Complete submission text file | 0000950170-24-049248.txt |  | 1010606

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37783 | Film No.: 24884645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)